The FDA has allowed the launch of a phase 2 study of MT027, an allogeneic chimeric antigen receptor (CAR) T-cell therapy ...
In Cycle-1REF Phase 2 clinical trial, tovinontrine demonstrated substantial reduction in NT-proBNP, a biomarker for heart failure, in patients with HFrEF on top of guideline-directed medical therapy, ...
Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing ...
CD122 inhibitor met its primary endpoint in a 126-patient study, demonstrating protection against gluten-induced intestinal damage and supporting advancement into late-stage clinical development. Key ...
Mentara Therapeutics has launched as a new neuropsychiatry company backed by SPRIM Global Investments and acquired MTA-304, a ...
As power density soars, air and single-phase loops hit their limits. A new webinar from Advanced Cooling technologies (ACT) shows how loop thermosyphons and pumped two-phase cooling unlock higher ...
Monolithic boost converters can convert low input voltages to a higher output voltage, all in a compact solution size. However, when the output power requirements increase, so do current levels and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results